obesity tirzepatide (ZEPBOUND) Approved for Chronic Weight Management in Adults with ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or The promise of tirzepatide: A

Xichen Lin, PhD, Chief Scientific Officer

Ozempic , Wegovy , and Rybelsus are registered trademarks of Novo Nordisk A/S

"The peptide capabilities made possible through this acquisition position the company in the coming years to explore exciting advances in peptide innovation, including across areas of consumer need such as preventive health, metabolic optimization, cognitive performance, recovery science, and biological resistances," executives said in a press release

Compounded GLP-1 products can differ between pharmacies

The STEP-1 trial (N=1,961) showed 14.9% mean body weight loss with semaglutide 2.4 mg at 68 weeks